Power of US hospital purchasing organisations to be investigated
This article was originally published in Clinica
Executive Summary
A congressional panel has decided to investigate the effect group purchasing organisations (GPOs) have on smaller medical device companies. The Senate Judiciary Committee's subcommittee on antitrust, business rights and competition says it intends to hold a hearing on "the competitive impact of hospital group purchasing organisations on smaller, innovative medical device manufacturers trying to market their products". The first step is expected to be a hearing, perhaps as early as this summer.
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.